Mesenchymal Stem Cells Attenuates TGF-β1-Induced EMT by Increasing HGF Expression in HK-2 Cells

Background: mesenchymal stem cells (mscs) have recently shown promise for the treatment of various types of chronic kidney disease models. however, the mechanism of this effect is still not well understood. our study is aimed to investigate the effect of mscs on transforming growth factor beta 1 (tgf-β1)-induced epithelial mesenchymal transition (emt) in renal tubular epithelial cells (hk-2 cells) and the underlying mechanism related to the reciprocal balance between hepatocyte growth factor (hgf) and tgf-β1. methods: our study was performed at ningbo university, ningbo, zhejiang, china between mar 2017 and jun 2018. hk-2 cells were initially treated with tgf-β1，then co-cultured with mscs. the induced emt was assessed by cellular morphology and the expressions of alpha-smooth muscle actin (α-sma) and emt-related proteins. mts assay and flow cytometry were employed to detect the effect of tgf-β1 and mscs on hk-2 cell proliferation and apoptosis. sirna against hepatocyte growth factor (sihgf) was transfected to decrease the expression of hgf to identify the role of hgf in mscs inhibiting hk-2 cells emt. results: overexpressing tgf-β1 decreased hgf expression, induced emt, suppressed proliferation and promoted apoptosis in hk-2 cells; but when co-cultured with mscs all the outcomes were reversed. however, after treated with sihgf, all the benefits taken from mscs vanished. conclusion: tgf-β1 was a motivating factor of kidney cell emt and it suppressed the hgf expression. however, mscs provided protection against emt by increasing hgf level and decreasing tgf-β1 level. our results also demonstrated hgf is one of the critical factor in mscs anti- fibrosis.